Misplaced Pages

DPH-362

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
DPH-362 is a simplified chemical analog of amitriptyline.

Pharmaceutical compound
DPH-362
Clinical data
Other namesPD129167
Identifiers
IUPAC name
  • N,N-dimethyl-4,4-diphenylbut-3-en-1-amine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H21N
Molar mass251.373 g·mol
3D model (JSmol)
SMILES
  • CN(C)CCC=C(C1=CC=CC=C1)C2=CC=CC=C2
InChI
  • InChI=InChI=1S/C18H21N/c1-19(2)15-9-14-18(16-10-5-3-6-11-16)17-12-7-4-8-13-17/h3-8,10-14H,9,15H2,1-2H3
  • Key:ZRPJJBLGKLVADE-UHFFFAOYSA-N

DPH-362 is a simplified amitriptyline analog created by omission of the two-carbon dibenzosuberane bridge (the seven membered ring). The resulting compound still had activity in a test to explore TCA sodium channel blockers with analgesic properties.

It is based on previous structures such as Spasmolytic A29 (one of the active ingredients in Ketogan) and SKF-89976A.

See also

References

  1. Bölcskei H, Tarnawa I, Kocsis P (June 2008). "Voltage-gated sodium channel blockers, 2001-2006: An overview". Medicinal Chemistry Research. 17 (2–7): 356–368. doi:10.1007/s00044-007-9071-2.
  2. Hudgens DP, Taylor C, Batts TW, Patel MK, Brown ML (December 2006). "Discovery of diphenyl amine based sodium channel blockers, effective against hNav1.2". Bioorganic & Medicinal Chemistry. 14 (24): 8366–8378. doi:10.1016/j.bmc.2006.09.010. PMC 2756728. PMID 17035036.
  3. Petersen PV (1951). "Studies on a new spasmolytic compound 1,1-diphenyl-3-dimethylaminobutene-1 (A29), related to methadone, and on the combined use of this compound and a potent analgesic, ketobemidone (A21)". Acta Pharmacologica et Toxicologica. 7 (1): 51–64. doi:10.1111/j.1600-0773.1951.tb02849.x. PMID 14829296.
  4. Ebert B, Thorkildsen C, Andersen S, Christrup LL, Hjeds H (September 1998). "Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists". Biochemical Pharmacology. 56 (5): 553–559. doi:10.1016/s0006-2952(98)00088-4. PMID 9783723.
Ion channel modulators
Calcium
VDCCsTooltip Voltage-dependent calcium channels
Blockers
Activators
Potassium
VGKCsTooltip Voltage-gated potassium channels
Blockers
Activators
IRKsTooltip Inwardly rectifying potassium channel
Blockers
Activators
KCaTooltip Calcium-activated potassium channel
Blockers
Activators
K2PsTooltip Tandem pore domain potassium channel
Blockers
Activators
Sodium
VGSCsTooltip Voltage-gated sodium channels
Blockers
Activators
ENaCTooltip Epithelial sodium channel
Blockers
Activators
ASICsTooltip Acid-sensing ion channel
Blockers
Chloride
CaCCsTooltip Calcium-activated chloride channel
Blockers
Activators
CFTRTooltip Cystic fibrosis transmembrane conductance regulator
Blockers
Activators
Unsorted
Blockers
Others
TRPsTooltip Transient receptor potential channels
LGICsTooltip Ligand gated ion channels
See also: Receptor/signaling modulatorsTransient receptor potential channel modulators
Local anesthetics (primarily sodium channel blockers) (N01B)
Esters by acid
Aminobenzoic
Benzoic
ArCO2- (not para-amino or Ph)
Amides
Combinations
Analgesics (N02A, N02B)
Opioids
Opiates/opium
Semisynthetic
Synthetic
Paracetamol-type
NSAIDs
Propionates
Oxicams
Acetates
COX-2 inhibitors
Fenamates
Salicylates
Pyrazolones
Others
Cannabinoids
Ion channel
modulators
Calcium blockers
Sodium blockers
Potassium openers
Myorelaxants
Others
Anticonvulsants (N03)
GABAergics
GABAAR PAMs
GABA-T inhibitors
Others
Channel
modulators
Sodium blockers
Calcium blockers
Potassium openers
Others
CA inhibitors
Others


Stub icon

This analgesic-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
DPH-362 Add topic